Effect of Perioperative Nicorandil on Myocardial Protection in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass, a Retrospective Study

References

• Hövels-Gürich HH, Vazquez-Jimenez JF, Silvestri A, et al. Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries. J Thoracic Cardiovasc Surg. 2002;124(4):811–820. doi:10.1067/mtc.2002.122308
   PubMed Web of Science ®Google Scholar
• Bosnjak ZJ, Ge ZD. The application of remote ischemic conditioning in cardiac surgery. F1000Research. 2017;6:928. doi:10.12688/f1000research.11018.1
   PubMedGoogle Scholar
• Ucak HA, Uncu H. Impact of coronary collateral circulation of perioperative myocardial damage in high-risk patients undergoing coronary artery bypass grafting surgery. Heart Surg Forum. 2019;22(5):E375–e9. doi:10.1532/hsf.2483
   PubMed Web of Science ®Google Scholar
• Wei M, Kuukasjarvi P, Laurikka J, et al. Cytokine responses and myocardial injury in coronary artery bypass grafting. Scand J Clin Lab Invest. 2001;61(2):161–166. doi:10.1080/00365510151097700
   PubMed Web of Science ®Google Scholar
• Nesher N, Zisman E, Wolf T, et al. Strict thermoregulation attenuates myocardial injury during coronary artery bypass graft surgery as reflected by reduced levels of cardiac-specific troponin I. Anesthesia Analg. 2003;96(2):328–335. doi:10.1213/00000539-200302000-00007
   PubMed Web of Science ®Google Scholar
• Uhlig C, Labus J. Volatile versus intravenous anesthetics in cardiac anesthesia, a narrative review. Curr Anesthesiol Rep. 2021;11(3):275–283. doi:10.1007/s40140-021-00466-1
   PubMedGoogle Scholar
• Liu Y, Paterson M, Baumgardt SL, et al. Vascular endothelial growth factor regulation of endothelial nitric oxide synthase phosphorylation is involved in isoflurane cardiac preconditioning. Cardiovascul Res. 2019;115(1):168–178. doi:10.1093/cvr/cvy157
   PubMed Web of Science ®Google Scholar
• Chao HH, Hong HJ, Sung LC, Chen JJ, Cheng TH, Liu JC. Nicorandil attenuates cyclic strain-induced endothelin-1 expression via the induction of activating transcription factor 3 in human umbilical vein endothelial cells. Eur J Pharmacol. 2011;667(1–3):292–297. doi:10.1016/j.ejphar.2011.05.062
   PubMed Web of Science ®Google Scholar
• Camm AJ, Maltz MB. A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris. Am J Cardiol. 1989;63(21):61j–5j. doi:10.1016/0002-9149(89)90207-5
   PubMed Web of Science ®Google Scholar
• Sakata Y, Kodama K, Komamura K, et al. Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction. Am Heart J. 1997;133(6):616–621. doi:10.1016/S0002-8703(97)70162-5
   PubMed Web of Science ®Google Scholar
• IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina, the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet. 2002;359(9314):1269–1275. doi:10.1016/S0140-6736(02)08265-X
   PubMed Web of Science ®Google Scholar
• Wang ZQ, Chen MX, Liu DL, et al. The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction. Zhonghua xin xue guan bing za zhi. 2017;45(1):26–33. doi:10.3760/cma.j.issn.0253-3758.2017.01.006
   PubMedGoogle Scholar
• Nishimura M, Tokoro T, Nishida M, et al. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients, a randomized trial. Am J Kidney Dis. 2009;54(2):307–317. doi:10.1053/j.ajkd.2009.03.025
   PubMed Web of Science ®Google Scholar
• Umemura S, Nakamura S, Sugiura T, et al. Preservation of myocardial viability within the risk area by intravenous nicorandil before primary coronary intervention in patients with acute myocardial infarction. Nuclear med commun. 2008;29(11):956–962. doi:10.1097/MNM.0b013e32830fdde7
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Yamada T, Kotake Y, Takeda J. Cardioprotective effects of nicorandil in patients undergoing on-pump coronary artery bypass surgery. J Cardiothor Vascul Anesth. 2008;22(4):548–553. doi:10.1053/j.jvca.2008.02.011
   PubMed Web of Science ®Google Scholar
• Mauermann E, Bolliger D, Fassl J, et al. Postoperative high-sensitivity troponin and its association with 30-day and 12-month, all-cause mortality in patients undergoing on-pump cardiac surgery. Anesthesia Analg. 2017;125(4):1110–1117. doi:10.1213/ANE.0000000000002023
   PubMed Web of Science ®Google Scholar
• Disease K; Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Polskie Archiwum Medycyny Wewn?trznej. 2013;120(7–8):300–306.
   Google Scholar
• Majumder K, Spratt JR, Holley CT, et al. Impact of postoperative liver dysfunction on survival after left ventricular assist device implantation. Ann Thorac Surg. 2017;104(5):1556–1562. doi:10.1016/j.athoracsur.2017.04.048
   PubMed Web of Science ®Google Scholar
• Schober P, Vetter TR. Propensity score matching in observational research. Anesthesia Analg. 2020;130(6):1616–1617. doi:10.1213/ANE.0000000000004770
   PubMed Web of Science ®Google Scholar
• Kim JH, Jeong MH, Yun KH, et al. Myocardial protective effects of nicorandil during percutaneous coronary intervention in patients with unstable angina. Circ J. 2005;69(3):306–310. doi:10.1253/circj.69.306
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kim W, Woo JS, et al. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention, a randomized controlled trial. Int J Cardiol. 2012;158(1):88–92. doi:10.1016/j.ijcard.2011.01.011
   PubMed Web of Science ®Google Scholar
• Xu L, Wang L, Li K, Zhang Z, Sun H, Yang X. Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction, a meta-analysis of randomized controlled trials. Drug Des Devel Ther. 2019;13:1389–1400. doi:10.2147/DDDT.S195918
   PubMed Web of Science ®Google Scholar
• Miyake K, Yoshida S, Seki T, Joo WJ, Takeuchi M, Kawakami K. Effectiveness of intraoperative nicorandil in patients with a history of ischemic heart disease undergoing high-risk noncardiac surgery, a retrospective cohort study. J Anesth. 2023;37(4):562–572. doi:10.1007/s00540-023-03204-5
   PubMed Web of Science ®Google Scholar
• Kaneko T, Hayashida M, Saito Y, Hikawa Y, Yasuda K. 虚血性心疾患危険因子を有する患者の開腹術におけるニコランジルの術中心筋虚血予防効果 [The effect of prophylactic nicorandil infusion to reduce intraoperative myocardial ischemia during abdominal surgery in patients with risk factors of ischemic heart disease]. Masui Japan J Anesthesiol. 2000;49(1):54–59. Japanese.
   PubMedGoogle Scholar
• Blanc P, Aouifi A, Bouvier H, et al. Safety of oral nicorandil before coronary artery bypass graft surgery. Br J Anaesth. 2001;87(6):848–854. doi:10.1093/bja/87.6.848
   PubMed Web of Science ®Google Scholar
• Minamiyama Y, Takemura S, Hai S, Suehiro S, Okada S, Funae Y. Nicorandil elevates tissue cGMP levels in a nitric-oxide-independent manner. J Pharmacol Sci. 2007;103(1):33–39. doi:10.1254/jphs.FP0061003
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Oshima K, Sato H, et al. The effect of nicorandil on ischemia-reperfusion injury in a porcine total hepatic vascular exclusion model. J Surg Res. 2011;167(1):49–55. doi:10.1016/j.jss.2009.09.049
   PubMed Web of Science ®Google Scholar
• Mohamed YS, Ahmed LA, Salem HA, Agha AM. Role of nitric oxide and KATP channel in the protective effect mediated by nicorandil in bile duct ligation-induced liver fibrosis in rats. Biochem. Pharmacol. 2018;151:135–142. doi:10.1016/j.bcp.2018.03.003
   PubMed Web of Science ®Google Scholar
• Abe K, Horiguchi T, Enzan K, Masaki Y, Nishikawa T, Kimura T. Nicorandil, a K(ATP) channel opener, attenuates ischemia-reperfusion injury in isolated rat lungs. Lung. 2020;198(2):315–321. doi:10.1007/s00408-020-00339-0
   PubMed Web of Science ®Google Scholar
• Wang C, Wu Z, Li Z, Wang Z, Ke H, Huang X. Beneficial effect of the mitochondrial ATP‑sensitive potassium channel‑specific opener nicorandil on the collapsed lung via inhibition of apoptosis in clinical thoracic surgery. Mole Med Rep. 2023;27(3). doi:10.3892/mmr.2023.12948
   Web of Science ®Google Scholar
• Peng YW, Major T, Deatrick KB, Mohammed A, Jeakle M, Charpie JR. Nicorandil attenuates ventricular dysfunction and organ injury after cardiopulmonary bypass. Int J Cardiol. 2022;368:62–68. doi:10.1016/j.ijcard.2022.08.030
   PubMed Web of Science ®Google Scholar
• Qian G, Zhang Y, Dong W, et al. Effects of nicorandil administration on infarct size in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention, the CHANGE trial. J Am Heart Assoc. 2022;11(18):e026232. doi:10.1161/JAHA.122.026232
   PubMed Web of Science ®Google Scholar